Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients.
Chiara Massa,Thomas Karn, Karsten Weber,Andreas Schneeweiss,Claus Hanusch,Jens Uwe Blohmer, Dirk-Michael Zahm,Christian Jackisch,Marion van Mackelenbergh,Jörg Thomalla,Frederik Marmé,Jens Huober,Volkmar Müller,Christian Schem, Anja Müller,Elmar Stickeler,Katharina Biehl,Peter A Fasching,Michael Untch,Sibylle Loibl,Carsten Denkert,Barbara Seliger Clinical and translational medicine（2024）
AI 理解论文
溯源树
样例
